Medications

FDA approves once-a-day inhaler from Glaxo

The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.

Medications

US panel backs inhaler drug for lung disease

A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.

Cardiology

Preventing heart disease requires a universal approach

Preventive cardiology is now on the political as well as clinical agenda. In 2011 a UN heads-of-state meeting agreed to reduce mortality from chronic non-communicable diseases (NCDs) by 25% by 2025.

Diseases, Conditions, Syndromes

Severity of emphysema predicts mortality

Severity of emphysema, as measured by computed tomography (CT), is a strong independent predictor of all-cause, cardiovascular, and respiratory mortality in ever-smokers with or without chronic obstructive pulmonary disease ...

Diseases, Conditions, Syndromes

COPD patients at risk of dangerous bacterial infections

It is well known that COPD patients run a higher risk of contracting respiratory infections. However, a new thesis from Lund University in Sweden shows that they are also at higher risk of other bacterial infections, such ...

page 17 from 23